The appointments of Burkhard Feurstein and Michael Armbruester to board members of Pantec Biosolutions are set to enhance future business and finance strategies for the company.
The German company, based in Liechtenstein, develops innovative technologies for transdermal drug delivery. Feurstein is director of finance at Gamma Capital Partners AG (GCP), a venture capital investment company, and has over 20 years expertise in investment and project finance, including a decade of direct and fund investment experience.
His core expertise lies in finance and turn-around management with operative experience as an industrial manager in the biopharmaceuticals and medical technology industries. Meanwhile, has held numerous board positions, developing a network of contacts in the venture capital and hedge fund sectors. He formed JB Commodities in early 2005. In just three years, the Company, which specialises in physical commodity trading and financial futures, has established four offices in four countries and is headquartered in Switzerland.
Christof Boehler, ceo and board member said: "We are delighted to have Burkhard Feurstein and Michael Armbruester on board since they both bring substantial expertise in corporate finance, management and mergers and acquisitions.
"With the addition of their skills, we are ideally positioned to plan the Company's future finance and business strategy especially with regard to our target financial exit strategy, an IPO."
